Fibrinogen Aa Chain Leu 554: an African-American kindred with late onset renal amyloidosis

References

• McDonagh J., Kaczmarek E, Lee M H. Fibrinogen and factor XIII: biology and disorders of fibrin formation and cross-linking. Blood: Principles and Practice of Hematology, R I Handin, S E Lux, T P Stossel. J.B.Lippincott Company, Philadelphia, PA 1995; 1219–1259
   Google Scholar
• Mills K, Buetow A., Xu K H., Weber Y., Altherr J. L.M.R., Wasmuth J J, Murray J C. Genetic and physical maps of human chromosome 4 based on dinucleotide repeats. Genomics 1992; 14: 209–219
   PubMed Web of Science ®Google Scholar
• Heinrich J, Funke H, Rust S, Schulte H, Schonfeld R, Kohler E, Assmann G. Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients. Thromb Res 1995; 77: 209–215
   Google Scholar
• Benson M D, Liepnieks J, Uemichi T, Wheeler G, Correa R. Hereditary renal amyloidosis associated with a mutant fibrinogen a-chain. Nature Genet 1993; 3: 252–255
   PubMed Web of Science ®Google Scholar
• Uemichi T, Liepnieks J J, Benson M D. Hereditary renal amyloidosis with a novel variant fibrinogen. J Clin Invest 1994; 93: 731–736
   PubMed Web of Science ®Google Scholar
• Uemichi T, Liepnieks J J, Yamada T, Gertz M A, Bang N, Benson M D. A frame shift mutation in the fibrinogen Aa chain gene in a kindred with renal amyloidosis. Blood 1996; 87: 4197–4203
   PubMed Web of Science ®Google Scholar
• Uemichi T, Liepnieks J J, Alexander F, Benson M D. The molecular basis of renal amyloidosis in Irish-American and Polish-Canadian kindreds. Q J Med 1996; 89: 745–750
   Google Scholar
• di AslHami L, Liepnieks J J, Uemichi T, Rebebou J M, Justrabo E, Droz D, Mousson C, Chalopin J M, Benson M D, Delpech M, Grateau G. Renal amyloidosis with a frame shift mutation in fibrinogen Aa chain gene producing a novel amyloid protein. Blood 1997; 90: 4799–4805
   Google Scholar
• Madisen L, Hoar D I, Holroyd C D, Crisp M, Hodes M E. DNA banking: The effects of storage of blood and isolated DNA on the integrity of DNA. Am J Med Genet 1987; 27: 379–390
   PubMed Web of Science ®Google Scholar
• Chung D W, Harris J E, Davie E W. Nucleotide sequences of the three genes coding for human fibrinogen. Advances in Experimental Medicine and Biology, C Y Liu, S Chien. Plenum Press, New York 1991; 281: 39–48
   Google Scholar
• Benson M D, Uemichi T. Transthyretin amyloidosis. Amyloid: Int J Exp Clin Invest 1996; 3: 44–56
   Web of Science ®Google Scholar
• Sequeiros J, Sousa A, Coelho T. Sex differences and age-dependent penetrance in FAP-type 1. Amyloid and Amyloidosis 1990, J B Natvig, O Forre, G Husby, A Husebekk, B Skogen, K Sletten, P Westermark. Kluwer Academic Publishers, Dordrecht, Boston, London 1991; 687–690
   Google Scholar
• Araki S, Ikegawa S, Okamoto N, Murakami T, Ando Y, Yi S. Epidemiological study of familial amyloidotic polyneuropathy (FAP) in Kumamoto focus, Japan. Neuromuscular Disord 1996; 6: S39
   Google Scholar
• Holmgren G, Costa P M, Anderson C, Asplund K, Steen L, Beckman L, Nylander P O, Teixeira A, Saraiva M J, Costa P P. Geographical distribution of TTR met 30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Genet 1994; 31: 351–354
   PubMed Web of Science ®Google Scholar
• Saunders A M, Schmader K, Breitner J CS, Benson M D, Brown W T, Goldfarb L, Goldgaber D, Manwaring M G, Szymanski M H, McCown N, Dole K C, Schmechel D E, Strittmatter W J, Pericak-Vance M A, Roses A D. Apolipoprotein E4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993; 342: 710–711
   PubMed Web of Science ®Google Scholar
• Gonnerman W A, Elliott-Bryant R, Carreras I, Sipe J D, Cathcart E S. Linkage of protection against amyloid fibril formation in the mouse to a single, autosomal dominant gene. J Exp Med 1995; 181: 2249–2252
   PubMed Web of Science ®Google Scholar
• Naiki H, Higuchi K, Shimada A, Takeda T, Nakakuki K. Genetic analysis of murine senile amyloidosis. Lab Invest 1993; 68: 332–337
   PubMedGoogle Scholar
• Yi S, Takahashi K, Araki S, Yamamura K. Transgenic mouse model of familial amyloidotic polyneuropathy type I: Its production, biological features, and usefulness. Lab Animal Sci 1995; 45: 173–175
   Google Scholar
• Waits R P, Uemichi T, Zeldenrust S, Hull M T, Field L, Benson M D. Development of lines of transgenic mice expressing the human transthyretin Ser 84 variant. Neuromuscular Disord 1996; 6: S31
   Google Scholar
• Teng M, Gallo G, Buxbaum J. Is amyloidogenic substrate enough? Transgenic mice producing human TTR Pro55 do not develop amyloid. Neuromuscular Disord 1996; 6: S30
   Google Scholar
• Bonifacio M J, Sakaki Y, Saraiva M J. Further characterization of transgenic mice, carrying the human TTR Met30 gene under the control of mouse metalothionein promoter gene, lacking amyloid deposition. Neuromuscular Disord 1996; 6: S32
   Google Scholar